CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 54 filers reported holding CIDARA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,391,686 | -46.6% | 2,538,406 | -35.9% | 0.20% | -52.9% |
| Q2 2023 | $4,476,945 | -25.5% | 3,961,898 | -16.2% | 0.43% | -5.9% |
| Q1 2023 | $6,006,634 | +81.8% | 4,729,633 | +8.3% | 0.46% | +115.0% |
| Q4 2022 | $3,303,113 | +13.0% | 4,367,464 | -4.2% | 0.21% | +13.2% |
| Q3 2022 | $2,924,000 | +24.2% | 4,559,201 | -5.4% | 0.19% | +60.2% |
| Q2 2022 | $2,355,000 | -42.9% | 4,819,090 | -2.7% | 0.12% | -35.5% |
| Q1 2022 | $4,126,000 | -38.4% | 4,954,882 | -6.0% | 0.18% | -22.1% |
| Q4 2021 | $6,693,000 | – | 5,270,458 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 1,508,794 | $6,639,000 | 3.14% |
| INTERWEST VENTURE MANAGEMENT CO | 1,356,813 | $5,970,000 | 2.92% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 437,357 | $1,924,000 | 2.88% |
| Stonepine Capital Management, LLC | 656,148 | $2,887,000 | 1.69% |
| Opaleye Management Inc. | 1,200,000 | $5,280,000 | 1.34% |
| FRAZIER MANAGEMENT LLC | 1,312,258 | $5,774,000 | 1.06% |
| Aisling Capital LLC | 1,021,148 | $4,493,000 | 0.97% |
| Prosight Management, LP | 324,902 | $1,430,000 | 0.80% |
| BVF INC/IL | 1,930,670 | $8,495,000 | 0.75% |
| Monashee Investment Management LLC | 480,851 | $2,116,000 | 0.45% |